145 related articles for article (PubMed ID: 33079233)
1. Verrucous esophageal carcinoma is a unique indolent subtype of squamous cell carcinoma: a systematic review and individual patient regression analysis.
Li DK; Haffar S; Horibe M; Homsi HA; Zukerberg L; Murad MH; Visrodia KH; Gala M; Katzka DA; Bazerbachi F
J Gastroenterol; 2021 Jan; 56(1):12-24. PubMed ID: 33079233
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic diagnosis and treatment of esophageal verrucous squamous cell cancer.
Sweetser S; Jacobs NL; Wong Kee Song LM
Dis Esophagus; 2014 Jul; 27(5):452-6. PubMed ID: 23067443
[TBL] [Abstract][Full Text] [Related]
3. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
[TBL] [Abstract][Full Text] [Related]
4. Verrucous carcinoma of the oesophagus is a genetically distinct subtype of oesophageal squamous cell carcinoma.
Isidro RA; Dong F; Hornick JL; Wee JO; Agoston A; Patil DT; Deshpande V; Zhao L
Histopathology; 2021 Oct; 79(4):642-649. PubMed ID: 33960520
[TBL] [Abstract][Full Text] [Related]
5. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
[TBL] [Abstract][Full Text] [Related]
7. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
8. Esophageal carcinoma with SMARCA4 mutation: Unique diagnostic challenges.
Cui M; Lemmon K; Jin Z; Uboha NV
Pathol Res Pract; 2023 Aug; 248():154692. PubMed ID: 37459679
[TBL] [Abstract][Full Text] [Related]
9. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
[TBL] [Abstract][Full Text] [Related]
11. Clinical and translational advances in esophageal squamous cell carcinoma.
Reichenbach ZW; Murray MG; Saxena R; Farkas D; Karassik EG; Klochkova A; Patel K; Tice C; Hall TM; Gang J; Parkman HP; Ward SJ; Tétreault MP; Whelan KA
Adv Cancer Res; 2019; 144():95-135. PubMed ID: 31349905
[TBL] [Abstract][Full Text] [Related]
12. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.
Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C
Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145
[TBL] [Abstract][Full Text] [Related]
13. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic submucosal dissection for an atypical small verrucous carcinoma: a case report.
Abe T; Kato M; Itagaki M; Hamatani S; Kawahara Y; Ito S; Aizawa Y; Matsuda K; Sumiyama K
J Med Case Rep; 2016 Mar; 10():74. PubMed ID: 27036299
[TBL] [Abstract][Full Text] [Related]
15. Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions.
Wang M; Smith JS; Wei WQ
Ann N Y Acad Sci; 2018 Dec; 1434(1):59-69. PubMed ID: 29882970
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in elderly patients: a single-center retrospective cohort study.
Ishido K; Tanabe S; Katada C; Kubota Y; Furue Y; Wada T; Watanabe A; Koizumi W
Jpn J Clin Oncol; 2021 May; 51(6):895-904. PubMed ID: 33738500
[TBL] [Abstract][Full Text] [Related]
17. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
[TBL] [Abstract][Full Text] [Related]
18. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
Furukawa H; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Cancer Sci; 2018 Feb; 109(2):412-421. PubMed ID: 29168598
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics-based analysis of the lncRNA-miRNA-mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma.
Ye Z; Fang J; Wang Z; Wang L; Li B; Liu T; Wang Y; Hua J; Wang F; Fu Z
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32662828
[TBL] [Abstract][Full Text] [Related]
20. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
